Open AccessArticle by Mari Carmen Álvarez-Abril 1, Irma García-Alcover 1,2, Jordi Colonques-Bellmunt 1, Raquel Garijo 1, Manuel Pérez-Alonso 1,2,3, Rubén Artero 1,2,3 and Arturo López-Castel 1,2,3,* 1 Valentia BioPharma S.L., 46980 Paterna, Spain 2 Human Translational Genomics Group, Institute for Biotechnology and Biomedicine (BIOTECMED), University of Valencia, 46100 Burjasot, Spain 3 Incliva Biomedical Research Institute, 46010 Valencia, Spain * Author to whom correspondence should be...